Targeting of a STING Agonist to Perivascular Macrophages in Prostate Tumors Delays Resistance to Androgen Deprivation Therapy
Haider Al‐Janabi, K. Moyes, Richard J. Allen, Matthew Fisher, Mateus Crespo, Bora Gürel, Pasquale Rescigno, Johann Sebastian De Bono, Harry Nunns, Christopher Bailey, Anna Juncker‐Jensen, Munitta Muthana, Wayne Allen Phillips, Helen B. Pearson, Mary‐Ellen Taplin, , Claire E. Lewis
This study shows targeting a STING agonist to perivascular macrophages in ADT-treated prostate tumors delays castration resistance prostate cancer onset.
Journal for ImmunoTherapy of Cancer · Jul 1, 2024Peer-reviewedCancer Biology